IRIS
MINARI, Roberta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 145
NA - Nord America 54
AS - Asia 29
Totale 228
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 70
US - Stati Uniti d'America 53
IE - Irlanda 37
FR - Francia 14
IN - India 10
DE - Germania 6
GB - Regno Unito 5
PT - Portogallo 5
CN - Cina 4
FI - Finlandia 4
JP - Giappone 4
HK - Hong Kong 3
VN - Vietnam 3
NL - Olanda 2
TR - Turchia 2
CA - Canada 1
KR - Corea 1
MY - Malesia 1
NO - Norvegia 1
SE - Svezia 1
SG - Singapore 1
Totale 228
Salva come PNG Salva come JPEG
Città #
Dublin 37
Parma 13
Casina 11
Boardman 10
Delhi 7
Milan 6
Lisbon 5
Bottanuco 4
Ellicott City 4
Helsinki 4
Bremen 3
Correggio 3
Detroit 3
Hartford 3
Pisa 3
Quattro Castella 3
Shanghai 3
Vicopisano 3
Ashburn 2
Carate Brianza 2
Costa Mesa 2
Council Bluffs 2
Flushing 2
Ho Chi Minh City 2
Houston 2
London 2
Osaka 2
Southend 2
Tappahannock 2
Ahmedabad 1
Amsterdam 1
Arezzo 1
Arlington 1
Atlanta 1
Brooklyn 1
Cambridge 1
Cincinnati 1
Columbus 1
Dokuz 1
Dong Ket 1
Harada 1
Istanbul 1
Jacksonville 1
Keele 1
Kuala Lumpur 1
Lake Forest 1
Los Angeles 1
Medolla 1
Mercato San Severino 1
Misano Adriatico 1
Montichiari 1
Mumbai 1
Neuenkirchen 1
Oslo 1
Ottawa 1
Paola 1
Paris 1
Pune 1
Rockville 1
Salerno 1
Seattle 1
Sejong 1
Singapore 1
Stockholm 1
Tokyo 1
Tübingen 1
Urbino 1
Verona 1
Totale 186
Salva come PNG Salva come JPEG
Nome #
Detection of EGFR-Activating and T790M Mutations Using Liquid Biopsy in Patients With EGFR-Mutated Non–Small-Cell Lung Cancer Whose Disease Has Progressed During Treatment With First- and Second-Generation Tyrosine Kinase Inhibitors: A Multicenter Real-Life Retrospective Study, file e177fbc7-a7a8-50b0-e053-d805fe0adaee 46
Efficacy of the cdk4/6 dual inhibitor abemaciclib in egfr-mutated nsclc cell lines with different resistance mechanisms to osimertinib, file e177fbc7-275c-50b0-e053-d805fe0adaee 42
Combination of EGFR-TKIs and chemotherapy in advanced EGFR mutated NSCLC: review of the literature and future perspectives, file e177fbc7-9d28-50b0-e053-d805fe0adaee 36
PD-L1 SNPs as biomarkers to define benefit in patients with advanced NSCLC treated with immune checkpoint inhibitors, file e177fbc7-9e55-50b0-e053-d805fe0adaee 29
Expanding the Arsenal of FGFR Inhibitors: A Novel Chloroacetamide Derivative as a New Irreversible Agent With Anti-proliferative Activity Against FGFR1-Amplified Lung Cancer Cell Lines., file e177fbc6-8938-50b0-e053-d805fe0adaee 15
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report, file e177fbc7-a9e3-50b0-e053-d805fe0adaee 14
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC, file e177fbc7-4f23-50b0-e053-d805fe0adaee 12
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial, file e177fbc7-a01a-50b0-e053-d805fe0adaee 9
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy, file e177fbc7-a416-50b0-e053-d805fe0adaee 9
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights, file 9cbeafa1-8654-423e-ab82-f309ae8ac50e 6
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios, file e177fbc7-999b-50b0-e053-d805fe0adaee 3
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC, file e177fbc6-281f-50b0-e053-d805fe0adaee 2
The Prognostic Role of High Blood Cholesterol in Advanced Cancer Patients Treated With Immune Checkpoint Inhibitors, file e177fbc6-d564-50b0-e053-d805fe0adaee 2
A sulfonyl fluoride derivative inhibits EGFR L858R/T790M/C797S by covalent modification of the catalytic lysine, file e177fbc7-9c8b-50b0-e053-d805fe0adaee 2
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC, file e177fbc7-ef8c-50b0-e053-d805fe0adaee 1
17P Dynamic changes of CT-radiomic and systemic immune-inflammatory features predict the response to immune checkpoint inhibitors in advanced NSCLC patients, file e177fbc7-f074-50b0-e053-d805fe0adaee 1
A novel mutation in the nr0b1 gene in a family with monozygotic twin sisters and congenital adrenal hypoplasia affected children., file e177fbc8-19c6-50b0-e053-d805fe0adaee 1
Totale 230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 657
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 1 0 0 1
2021/202240 0 1 0 1 0 0 20 0 4 3 9 2
2022/2023159 11 0 4 18 8 5 12 21 42 4 18 16
2023/202429 3 0 4 4 1 1 7 5 3 0 1 0
Totale 230